시장보고서
상품코드
1090304

세계의 암로디핀 베실산염 시장(2022-2026년)

Global Amlodipine Besylate Market 2022-2026

발행일: | 리서치사: TechNavio (Infiniti Research Ltd.) | 페이지 정보: 영문 120 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 암로디핀 베실산염 시장 규모는 2022-2026년 2억 1,726만 달러의 증가가 전망되며, 예측 기간 중 CAGR로 3.6%의 성장이 예측됩니다.

시장은 고혈압의 발증률 상승, 기술의 진보, 암로디핀 베실산염의 높은 특이성, 감도, 정도에 의해 촉진되고 있습니다.

세계의 암로디핀 베실산염 시장에 대해 조사분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인·과제, 약 25사의 벤더를 다룬 벤더 분석 등을 정리하여 전해드립니다.

목차

제1장 개요

  • 시장 개요

제2장 시장 구도

  • 시장 에코시스템

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 : 2021년
  • 시장 전망 : 2021-2026년의 예측

제4장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 교섭력
  • 공급업체의 교섭력
  • 신규 기업의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 현황

제5장 시장 세분화 : 용도별

  • 시장 부문
  • 비교 : 용도별
  • 고혈압 - 시장 규모와 예측 : 2021-2026년
  • 심장병 - 시장 규모와 예측 : 2021-2026년
  • 시장 기회 : 용도별

제6장 고객 상황

  • 고객 상황의 개요

제7장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 - 시장 규모와 예측 : 2021-2026년
  • 유럽 - 시장 규모와 예측 : 2021-2026년
  • 아시아 - 시장 규모와 예측 : 2021-2026년
  • 기타 지역(ROW) - 시장 규모와 예측 : 2021-2026년
  • 미국 - 시장 규모와 예측 : 2021-2026년
  • 독일 - 시장 규모와 예측 : 2021-2026년
  • 영국 - 시장 규모와 예측 : 2021-2026년
  • 중국 - 시장 규모와 예측 : 2021-2026년
  • 캐나다 - 시장 규모와 예측 : 2021-2026년
  • 시장 기회 : 지역 상황별

제8장 촉진요인, 과제 및 동향

  • 시장 촉진요인
  • 시장이 해결해야 할 과제
  • 촉진요인과 과제의 영향
  • 시장 동향

제9장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란의 상황
  • 업계의 리스크

제10장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Amsal Chem Pvt. Ltd.
  • Aurobindo Pharma Ltd.
  • Cadila Pharmaceuticals Ltd.
  • CENTURY PHARMACEUTICALS Ltd.
  • Changzhou Yabang Pharmaceutical Co. Ltd.
  • Cipla Ltd.
  • Dr. Reddys Laboratories Ltd.
  • MOEHS IBERICA SL
  • Rakshit Drugs Pvt. Ltd.
  • VPL Chemicals Pvt. Ltd.

제11장 부록

KSA 22.06.24

Technavio has been monitoring the amlodipine besylate market and it is poised to grow by $ 217.26 mn during 2022-2026, accelerating at a CAGR of 3.6% during the forecast period. Our report on the amlodipine besylate market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of hypertension, technological advances, and the high specificity, sensitivity, and accuracy of amlodipine besylate.

The amlodipine besylate market analysis includes application segment and geographic landscape.

Technavio's amlodipine besylate market is segmented as below:

By Application

  • High blood pressure
  • Heart diseases

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing usage of amlodipine besylate in various treatments as one of the prime reasons driving the amlodipine besylate market growth during the next few years. Also, increasing investments in the healthcare sector and new developments in the industry will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the amlodipine besylate market covers the following areas:

  • Amlodipine besylate market sizing
  • Amlodipine besylate market forecast
  • Amlodipine besylate market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amlodipine besylate market vendors including Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., and Orbion Pharmaceuticals Pvt. Ltd. Also, the amlodipine besylate market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

  • 5.1 Market segments
  • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
  • 5.2 Comparison by Application
  • Exhibit 26: Chart on Comparison by Application
  • Exhibit 27: Data Table on Comparison by Application
  • 5.3 High blood pressure - Market size and forecast 2021-2026
  • Exhibit 28: Chart on High blood pressure - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on High blood pressure - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on High blood pressure - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on High blood pressure - Year-over-year growth 2021-2026 (%)
  • 5.4 Heart diseases - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Heart diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Heart diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Heart diseases - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Heart diseases - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Application
  • Exhibit 36: Market opportunity by Application ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Amsal Chem Pvt. Ltd.
  • Exhibit 85: Amsal Chem Pvt. Ltd. - Overview
  • Exhibit 86: Amsal Chem Pvt. Ltd. - Product / Service
  • Exhibit 87: Amsal Chem Pvt. Ltd. - Key offerings
  • 10.4 Aurobindo Pharma Ltd.
  • Exhibit 88: Aurobindo Pharma Ltd. - Overview
  • Exhibit 89: Aurobindo Pharma Ltd. - Product / Service
  • Exhibit 90: Aurobindo Pharma Ltd. - Key offerings
  • 10.5 Cadila Pharmaceuticals Ltd.
  • Exhibit 91: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibit 92: Cadila Pharmaceuticals Ltd. - Business segments
  • Exhibit 93: Cadila Pharmaceuticals Ltd. - Key offerings
  • Exhibit 94: Cadila Pharmaceuticals Ltd. - Segment focus
  • 10.6 CENTURY PHARMACEUTICALS Ltd.
  • Exhibit 95: CENTURY PHARMACEUTICALS Ltd. - Overview
  • Exhibit 96: CENTURY PHARMACEUTICALS Ltd. - Product / Service
  • Exhibit 97: CENTURY PHARMACEUTICALS Ltd. - Key offerings
  • 10.7 Changzhou Yabang Pharmaceutical Co. Ltd.
  • Exhibit 98: Changzhou Yabang Pharmaceutical Co. Ltd. - Overview
  • Exhibit 99: Changzhou Yabang Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 100: Changzhou Yabang Pharmaceutical Co. Ltd. - Key offerings
  • 10.8 Cipla Ltd.
  • Exhibit 101: Cipla Ltd. - Overview
  • Exhibit 102: Cipla Ltd. - Business segments
  • Exhibit 103: Cipla Ltd. - Key news
  • Exhibit 104: Cipla Ltd. - Key offerings
  • Exhibit 105: Cipla Ltd. - Segment focus
  • 10.9 Dr. Reddys Laboratories Ltd.
  • Exhibit 106: Dr. Reddys Laboratories Ltd. - Overview
  • Exhibit 107: Dr. Reddys Laboratories Ltd. - Business segments
  • Exhibit 108: Dr. Reddys Laboratories Ltd. - Key offerings
  • Exhibit 109: Dr. Reddys Laboratories Ltd. - Segment focus
  • 10.10 MOEHS IBERICA SL
  • Exhibit 110: MOEHS IBERICA SL - Overview
  • Exhibit 111: MOEHS IBERICA SL - Product / Service
  • Exhibit 112: MOEHS IBERICA SL - Key offerings
  • 10.11 Rakshit Drugs Pvt. Ltd.
  • Exhibit 113: Rakshit Drugs Pvt. Ltd. - Overview
  • Exhibit 114: Rakshit Drugs Pvt. Ltd. - Product / Service
  • Exhibit 115: Rakshit Drugs Pvt. Ltd. - Key offerings
  • 10.12 VPL Chemicals Pvt. Ltd.
  • Exhibit 116: VPL Chemicals Pvt. Ltd. - Overview
  • Exhibit 117: VPL Chemicals Pvt. Ltd. - Product / Service
  • Exhibit 118: VPL Chemicals Pvt. Ltd. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 119: Inclusions checklist
  • Exhibit 120: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 121: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 122: Research methodology
  • Exhibit 123: Validation techniques employed for market sizing
  • Exhibit 124: Information sources
  • 11.5 List of abbreviations
  • Exhibit 125: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제